The economic impact of cancer varies widely across countries due to differences in healthcare systems, availability of resources, and economic status. High-income countries may have better access to advanced treatments but also face higher costs. Low and middle-income countries often struggle with limited resources, leading to disparities in cancer care and outcomes.
